View Main Condition: Breast Cancer
Brian Czerniecki is a General Surgeon and a Surgical Oncologist in Tampa, Florida. Czerniecki has been practicing medicine for over 35 years and is rated as an Elite expert by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 11 other conditions, according to our data. His top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Mastectomy. Czerniecki is currently accepting new patients.
Ian Krop is an Oncologist in Boston, Massachusetts. Krop has been practicing medicine for over 27 years and is rated as an Elite expert by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 9 other conditions, according to our data. His top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma. Krop is currently accepting new patients.
Aleix Prat practices in Barcelona, Spain. Prat is rated as an Elite expert by MediFind in the treatment of HER-2 Positive Breast Cancer. He is also highly rated in 7 other conditions, according to our data. His top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, COVID-19, Endoscopy, and Mastectomy.
Summary: n the present study the neoadjuvant approach with the anti-HER2 trastuzumab and pertuzumab combined with carboplatin and paclitaxel will be used to compare the Event-Free Survival (EFS) in regimens with and without atezolizumab. Following the neoadjuvant part of the study, after surgery all patients will continue to receive trastuzumab and pertuzumab to complete one year of anti-HER2 therapy. Simi...
Summary: This clinical trial examines an investigational scan (64Cu-DOTA-trastuzumab positron emission tomography [PET]/magnetic resonance imaging [MRI]) in imaging patients with HER2+ breast cancer that has spread to the brain (brain metastasis). Diagnostic procedures, such as 64Cu-DOTA-trastuzumab PET/MRI, may help find HER2+ breast cancer that has spread to the brain and determine whether cancer in the ...